References
- Kitchen SG, Bennett M, Galić Z et al. Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice. PLoS ONE 4(12), e8208 (2009).
- Kitchen SG, Levin BR, Bristol G et al. In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells. PLoS Pathog. 8(4), e1002649 (2012).
- Busschots K, Voet A, De Maeyer M et al. Identification of the LEDGF/p75 binding site in HIV-1 integrase. J. Mol. Biol. 365(5), 1480–1492 (2007).
- De Luca L, Barreca ML, Ferro S et al. Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75. Chem. Med. Chem. 4(8), 1311–1316 (2009).
- Christ F, Shaw S, Demeulemeester J et al. Small-molecule inhibitors of the LEDGF/p75 binding site of integrase block HIV replication and modulate integrase multimerization. Antimicrob. Agents Chemother. 56(8), 4365–4374 (2012).
- Mariyanna L, Priyadarshini P, Hofmann-Sieber H et al. Excision of HIV-1 proviral DNA by recombinant cell permeable tre-recombinase. PLoS ONE 7(2), e31576 (2012).
Websites
- Joint United Nations Joint Programme on HIV/AIDS. Together we will end AIDS. www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/20120718_togetherwewillendaids_en.pdf
- International AIDS Society. www.iasociety.org